Cardinal Health, Inc. (CAH)
| Previous close | 103.81 |
| Open | 103.20 |
| Bid | 103.06 x 1200 |
| Ask | 103.09 x 1200 |
| Day's range | 102.93 - 103.94 |
| 52-week range | 77.56 - 116.04 |
| Volume | |
| Avg. volume | 2,370,875 |
| Market cap | 25.182B |
| Beta (5Y monthly) | 0.70 |
| PE ratio (TTM) | 41.08 |
| EPS (TTM) | 2.52 |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | 2.00 (1.93%) |
| Ex-dividend date | 28 Mar 2024 |
| 1y target est | 115.21 |
ZacksAre You a Value Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ZacksCencora (COR) to Report Q2 Earnings: What's in the Cards?
Cencora's (COR) second-quarter fiscal 2024 results are likely to reflect solid performance in the U.S. Healthcare Solutions segment.
- Reuters
UPDATE 2-US FDA sends warning letter to Cardinal Health for marketing unapproved devices
The U.S. health regulator has sent a warning letter to Cardinal Health after an inspection of its facility in Illinois found the company was marketing and distributing unapproved devices made by a Chinese manufacturer. The U.S. Food and Drug Administration in 2023 recommended against the use of some China-made syringes as it investigated reports of leaks, breakages and other quality problems with such products and last month expanded the guidance. Cardinal did not immediately respond to a Reuters request for comment.
